Cephacetrile in the treatment of acute bacterial pneumonia.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000942:Antigens, Bacterial; D001424:Bacterial Infections / Q000188:drug therapy* / Q000276:immunology; D002505:Cephacetrile / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002509:Cephaloridine / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D002512:Cephalothin / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000276:immunology / Q000302:isolation & purification
D000942:Antigens, Bacterial; D002511:Cephalosporins; D002505:Cephacetrile; D002509:Cephaloridine; D002512:Cephalothin